UBS Group’s LifeMD LFMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8M | Buy |
937,331
+859,444
| +1,103% | +$11.7M | ﹤0.01% | 2224 |
|
|
2025
Q1 | $424K | Sell |
77,887
-167,021
| -68% | -$909K | ﹤0.01% | 4790 |
|
|
2024
Q4 | $1.21M | Buy |
244,908
+86,785
| +55% | +$430K | ﹤0.01% | 4084 |
|
|
2024
Q3 | $829K | Buy |
158,123
+21,654
| +16% | +$113K | ﹤0.01% | 3733 |
|
|
2024
Q2 | $936K | Buy |
136,469
+136,306
| +83,623% | +$935K | ﹤0.01% | 3451 |
|
|
2024
Q1 | $1.68K | Buy |
+163
| New | +$1.68K | ﹤0.01% | 6910 |
|
|
2023
Q3 | – | Sell |
-975
| Closed | -$4.24K | – | 8513 |
|
|
2023
Q2 | $4.24K | Buy |
+975
| New | +$4.24K | ﹤0.01% | 6472 |
|
|
2023
Q1 | – | Sell |
-7,322
| Closed | -$14.2K | – | 8763 |
|
|
2022
Q4 | $14.2K | Buy |
+7,322
| New | +$14.2K | ﹤0.01% | 6912 |
|
|
2022
Q3 | – | Sell |
-2,295
| Closed | -$5K | – | 9467 |
|
|
2022
Q2 | $5K | Sell |
2,295
-2,322
| -50% | -$5.06K | ﹤0.01% | 7856 |
|
|
2022
Q1 | $16K | Buy |
4,617
+4,601
| +28,756% | +$15.9K | ﹤0.01% | 6695 |
|
|
2021
Q4 | $0 | Sell |
16
-1
| -6% | – | ﹤0.01% | 9261 |
|
|
2021
Q3 | $0 | Buy |
+17
| New | – | ﹤0.01% | 8579 |
|
|
2021
Q2 | – | Sell |
-3,631
| Closed | -$57K | – | 8433 |
|
|
2021
Q1 | $57K | Buy |
+3,631
| New | +$57K | ﹤0.01% | 5415 |
|